Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
6.23
-0.02 (-0.32%)
At close: Aug 7, 2026, 4:00 PM EDT
6.30
+0.07 (1.12%)
After-hours: Aug 7, 2026, 7:35 PM EDT

MRVI Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, MRVI stock has a consensus rating of "Buy" and an average price target of $7.10. The average 1-year stock price forecast is 13.96% higher than the current stock price, while the lowest is $5.50 (-11.72%) and the highest is $8.00 (+28.41%).

Price Target: $7.10 (+13.96%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.50$7.10$7.00$8.00
Change-11.72%+13.96%+12.36%+28.41%

Analyst Ratings

The average analyst rating for MRVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy555555
Buy000000
Hold544333
Sell000000
Strong Sell000000
Total1099888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Wells Fargo
No rating
Wells Fargo
Buy
Maintains
$5.5$6.5
BuyMaintains$5.5$6.5+4.33%Aug 7, 2026
William Blair
William Blair
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 7, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$4$6
BuyMaintains$4$6-3.69%May 12, 2026
Guggenheim
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aMay 11, 2026
Deutsche Bank
Deutsche Bank
Buy
Maintains
$4.5$6
BuyMaintains$4.5$6-3.69%May 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
210.64M
from 185.74M
Increased by 13.41%
Revenue Next Year
224.95M
from 210.64M
Increased by 6.79%
EPS This Year
-0.12
from -0.29
EPS Next Year
-0.09
from -0.12
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
799.24M883.00M288.95M259.19M185.74M210.64M
Revenue Growth
181.33%10.48%-67.28%-10.30%-28.34%13.41%
Operating Income
543.40M569.92M-28.47M-72.68M-125.63M-16.46M
Net Income
182.04M220.21M-119.03M-144.85M-130.77M-52.21M
EPS
-----0.29-0.12
Free Cash Flow
219.25M373.29M41.26M-7.50M-2.77M5.10M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High212.0M
Avg210.6M
Low208.6M

Revenue Growth

Revenue Growth202620272028
High
14.1%
Avg
13.4%
Low
12.3%

EPS Forecast

EPS202620272028
High-0.08
Avg-0.12
Low-0.17

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-